WHAT YOU NEED TO KNOW During a hearing before the Senate Finance Committee, United States Secretary of Health and Human Services Alex Azar highlighted the need for legislation to address Big Pharma’s use of patent thickets to abuse the American patent system. “Just one drug alone the savings from biosimilar market entry would be billions of dollars […]

Continue Reading

IN CASE YOU MISSED IT: Yesterday, during testimony before the Senate Finance Committee and amid questioning from U.S. Senator John Cornyn (R-TX), United States Secretary of Health and Human Services Alex Azar urged Congress to act and finally address Big Pharma’s use of patent thickets to expand their monopolies and maintain their drug high prices. As […]

Continue Reading

President Trump Addressed the Need for Affordable Generic Drugs at the SOTU, Patent Reform is a Critical Component WASHINGTON, D.C. – The Coalition Against Patent Abuse (CAPA) released the following statement regarding the Trump administration’s efforts to tackle rising prescription drug prices caused by big pharmaceutical companies in his 2020 State of the Union address to […]

Continue Reading